CMS Actively Looking For New Reimbursement Pathway For Innovative Devices

Securing market access for cutting-edge, costly medical devices may soon get easier. Lobbyists are inching closer to securing a policy with the CMS (US Centers for Medicare and Medicaid Services) to make access and reimbursement for high-cost, highly-innovative devices automatic (albeit temporary) under Medicare Coverage. Explore the pathways being forged as increasingly fast FDA approvals are producing a greater need for early adoption and data collection. Take a closer look at this issue, and at how the existing parallel review program has failed to move devices through to market, with only 2 devices making the grade in the past seven years.